Hantavirus Cruise Ship Cases: Not a Pandemic Threat, Assures Ex-FDA Head

Former FDA Commissioner Scott Gottlieb has assured the public that the hantavirus outbreak, linked to a cruise ship with returning passengers now in quarantine, is not expected to become a pandemic like COVID-19. He explained that hantavirus transmission requires close contact and that individuals are generally not contagious until symptoms appear, with the disease progressing rapidly. Gottlieb noted that while most cases are contained, a few outlier transmissions warrant attention.

Amidst concerns about public trust in health institutions, Gottlieb stressed that hantavirus spreads far less efficiently than coronaviruses and that ivermectin is not an effective treatment. He also addressed significant challenges within the U.S. Food and Drug Administration (FDA), highlighting substantial departures of medical reviewers, particularly in oncology and hematology. This upheaval, he stated, has been detrimental to the agency's operational capacity.

Gottlieb also commented on the use of antidepressants, urging individuals to consult their doctors before stopping treatment. He expressed concern that recent statements by Secretary Kennedy might discourage appropriate use of these potentially life-saving medications, drawing a parallel to previous comments on Tylenol use during pregnancy.